Recent developments in animal models for human herpesvirus 6A and 6B.

Progress in the identification of suitable animal models for human herpesvirus (HHV)-6A and HHV-6B infections has been slow. Recently, new models have been established, mainly for HHV-6A, which reproduce some pathological features seen in humans. Neuroinflammatory signs were observed in infected marmosets and CD46-transgenic mice; although viral replication was not prominent, persistence of viral DNA and specific immunologic responses were detected, suggesting an immune-mediated pathogenic mechanism. Pig-tailed macaques showed robust viral replication concomitant with acute-phase symptoms, and provided a model to study the effects of HHV-6A on AIDS progression. In humanized mice, viral replication was less evident, but infection led to T-cell alterations. Altogether, these recent developments have opened new perspectives for studying the pathogenic role of HHV-6A in humans.

[1]  J. Reynaud,et al.  Human Herpesvirus 6A Infection in CD46 Transgenic Mice: Viral Persistence in the Brain and Increased Production of Proinflammatory Chemokines via Toll-Like Receptor 9 , 2014, Journal of Virology.

[2]  L. Coscoy,et al.  Downregulation of the T-Cell Receptor Complex and Impairment of T-Cell Activation by Human Herpesvirus 6 U24 Protein , 2007, Journal of Virology.

[3]  E. Murphy,et al.  Human Herpesvirus 6 A Infection and Immunopathogenesis in Humanized Rag 2 / c / Mice , 2013 .

[4]  S. Yalcin,et al.  Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. , 1992, The Journal of general virology.

[5]  M. Mikaeili,et al.  Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  R. Gallo,et al.  In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo , 1990, Journal of virology.

[7]  R. Gallo,et al.  Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. , 1991, Journal of immunology.

[8]  P. Calabresi,et al.  Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA , 1997, Nature Medicine.

[9]  B. Berges,et al.  The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment , 2011, Retrovirology.

[10]  B. Becher,et al.  Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. , 2006, The Journal of clinical investigation.

[11]  C. Di Serio,et al.  Human herpesvirus 6A accelerates AIDS progression in macaques , 2007, Proceedings of the National Academy of Sciences.

[12]  A. Vaheri,et al.  Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications , 2011, Journal of NeuroVirology.

[13]  M. Malnati,et al.  CD46 Is a Cellular Receptor for Human Herpesvirus 6 , 1999, Cell.

[14]  F. Lori,et al.  Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6 , 1991, Nature.

[15]  Wiley Interscience,et al.  Quantitative analysis of human herpesvirus 6 cell tropism , 2005, Journal of medical virology.

[16]  E. Murphy,et al.  Human Herpesvirus 6A Infection and Immunopathogenesis in Humanized Rag2−/−γc−/− Mice , 2013, Journal of Virology.

[17]  A. Goodman,et al.  Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. , 2003, The Journal of infectious diseases.

[18]  K. Yamanishi,et al.  Seroepidemiology of human herpesvirus 6 infection in normal children and adults , 1989, Journal of clinical microbiology.

[19]  P. Mirandola,et al.  Human herpesvirus 6: An emerging pathogen. , 1999, Emerging infectious diseases.

[20]  P. Secchiero,et al.  In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. , 1994, AIDS research and human retroviruses.

[21]  J. McCune,et al.  Human Herpesvirus 6 (HHV-6) Causes Severe Thymocyte Depletion in SCID-hu Thy/Liv Mice , 1999, The Journal of experimental medicine.

[22]  J. Grivel,et al.  Pathogenic Effects of Human Herpesvirus 6 in Human Lymphoid Tissue Ex Vivo , 2003, Journal of Virology.

[23]  D. Reich,et al.  Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization , 2013, PLoS pathogens.

[24]  K. Yamanishi,et al.  IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM , 1988, The Lancet.

[25]  H. Agut Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  T. Naka,et al.  CD134 is a cellular receptor specific for human herpesvirus-6B entry , 2013, Proceedings of the National Academy of Sciences.

[27]  S. Gantt,et al.  Human Herpesvirus 6, 7 and 8 in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.